Joshua Hunter

Joshua Hunter is the Director and Head of ADC Conjugation Process Development at Pfizer, where they focus on the development of antibody drug conjugates. Previously, they held various roles in conjugation process development at Seagen, including Principal Scientist and Senior Scientist. Joshua also worked as a Post-Doctoral Research Associate at the University of Washington, conducting toxicology analyses and enzyme assays, and served as an Adjunct Professor of Chemistry at Seattle University. They obtained a Ph.D. in Organic Chemistry/Chemical Biology from the University of Washington, where they also earned a Master of Science and a Bachelor of Science in Chemistry.